Table 1.
Tumour subtypes | Study groups | |||||||
---|---|---|---|---|---|---|---|---|
TPAs | APAs | PCAs | Total | |||||
Number | % | Number | % | Number | % | Number | % | |
Densely granulated GH-cell adenomas | 5 | 2.5 % | 3 | 3.1 % | 0 | 0.0 % | 8 | 2.6 % |
Sparsely granulated GH-cell adenomas | 16 | 8.0 % | 11 | 11.2 % | 1 | 10.0 % | 28 | 9.1 % |
Mixed GH/PRL-cell adenomas | 9 | 4.5 % | 6 | 6.1 % | 0 | 0.0 % | 15 | 4.9 % |
PRL-cell adenomas | 64 | 32.0 % | 32 | 32.7 % | 2 | 20.0 % | 98 | 31.8 % |
Densely granulated ACTH-cell adenomas | 19 | 9.5 % | 8 | 8.2 % | 0 | 0.0 % | 27 | 8.8 % |
Sparsely granulated ACTH-cell adenomas | 49 | 24.5 % | 20 | 20.4 % | 0 | 0.0 % | 69 | 22.4 % |
ACTH-cell adenomas, NOS | 0 | 0.0 % | 0 | 0.0 % | 7 | 70.0 % | 7 | 2.3 % |
TSH-cell adenomas | 3 | 1.5 % | 2 | 2.0 % | 0 | 0.0 % | 5 | 1.6 % |
FSH/LH-cell adenomas | 10 | 5.0 % | 5 | 5.1 % | 0 | 0.0 % | 15 | 4.9 % |
Null cell adenomas | 25 | 12.5 % | 11 | 11.2 % | 0 | 0.0 % | 36 | 11.7 % |
Total | 200 | 100 % | 98 | 100 % | 10 | 100 % | 308 | 100 % |
The histological classification of each tumor analyzed in the groups of typical pituitary adenomas (TPA), atypical pituitary adenomas (APA) and pituitary carcinomas (PCA) is shown in detail. NOS not otherwise specified
GH growth hormone, PRL prolactin, ACTH adrenocorticotrophic hormone, TSH thyroid-stimulating hormone, FSH follicle-stimulating hormone, LH luteinizing hormone